Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer.

The Journal of clinical endocrinology and metabolism - 1 May 2009

Guan Haixia, Ji Meiju, Bao Rong, Yu Hongyu, Wang Yangang, Hou Peng, Zhang Yong, Shan Zhongyan, Teng Weiping, Xing Mingzhao

Abstract excerpt

CONTEXT: Epidemiological studies have indicated that high iodine intake might be a risk factor for papillary thyroid cancer (PTC), which commonly harbors the oncogenic T1799A BRAF mutation. OBJECTIVE: The objective of the study was to investigate the relationship between BRAF mutation in PTC and iodine intake in patients. SUBJECTS AND METHODS: We analyzed and compared the prevalences of the T1799A BRAF mutation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Papillary
Share to China

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Gene Frequency

Share to Odds Ratio

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Neoplasms

Share to Water Supply

Source

Identifiers

PMID: 19190105
DOI: 10.1210/jc.2008-2390

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer.PMID 19190105Read ↗

Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area.Semantic proximity Read ↗

The Relevance between Iodine Nutritional Status and BRAFV600E Mutation on Papillary Thyroid CancerSemantic proximity Read ↗

Iodine nutritional status is not a direct factor in the prevalence of the BRAFV600E mutation in papillary thyroid cancer.Semantic proximity Read ↗

The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancerSemantic proximity Read ↗

Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution Study.Semantic proximity Read ↗

Association of iodine nutritional status with thyroid nodules and papillary thyroid carcinoma in women from an iodine-sufficient region in Brazil: A cross-sectional center study.Semantic proximity Read ↗

BRAF V600E mutation in papillary thyroid cancer is correlated with adverse clinicopathological features but not with iodine exposureSemantic proximity Read ↗

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications.Semantic proximity Read ↗

Clinical significance of the BRAFV600E mutation in PTC and its effect on radioiodine therapySemantic proximity Read ↗

Low Urinary Iodine is a Protective Factor of Central Lymph Node Metastasis in Papillary Thyroid Cancer: A Cross-sectional StudySemantic proximity Read ↗

Correlation between polymorphisms of BRAF gene and papillary thyroid carcinoma.Semantic proximity Read ↗

High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.